← All organizations

Myelo Therapeutics GmbH

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 1, 2016

Timeline

2010s

Jun 1, 2013
Myelo Therapeutics GmbH— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

imidazolyl ethanamide pentandioic acid

Indications

Studied for

Recent trials (2)

NCT02692742Study directorPhase 2Mar 1, 2016
NCT02692742Lead sponsorPhase 2Mar 1, 2016

Details

Founded: Berlin, DE Jun 1, 2013
Last known activity: Mar 1, 2016